Vontier Corp. (VNT) Reports In-Line Q3 EPS; Offers FY22 EPS Guidance

Go back to Vontier Corp. (VNT) Reports In-Line Q3 EPS; Offers FY22 EPS Guidance
Savient Pharmaceuticals, Inc. (NYSE: VNT) Delayed: 32.23 -0.34 (1.04%)
Previous Close $32.57    52 Week High $9.92 
Open $32.35    52 Week Low $9.10 
Day High $32.57    P/E N/A 
Day Low $32.06    EPS $-0.94 
Volume 119,281